Atomi Financial Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
Atomi Financial Group's BIIB Position: Q1 2026 in Review
Atomi Financial Group reduced its Biogen (BIIB) stake by 16% in Q1 2026, selling an estimated $98.8K and leaving 2,742 shares worth $503K. The position accounts for 0.02% of the portfolio, ranked #712.
Atomi Financial Group first reported a position in BIIB in Q2 2025 and has held it in 3 quarters since. The position peaked at $577K in Q4 2025. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Atomi Financial Group held 2,742 shares of Biogen worth $503K as of Q1 2026.
- Atomi Financial Group sold 536 Biogen shares in Q1 2026, an estimated $98.8K.
- Biogen made up 0.02% of Atomi Financial Group's portfolio in Q1 2026, its #712 holding.
- Atomi Financial Group first reported a position in Biogen in Q2 2025 and has held it in 3 quarters since.
- Atomi Financial Group's Biogen position peaked at $577K in Q4 2025.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.